According to GlobalData forecasts, the US market alone will see sales of $2.7 billion in 2025, driven by the advances that ...
US biotech Halozyme Therapeutics has entered into a definitive agreement to acquire Elektrofi, a biopharma with a ...
Anglo-Dutch precision oncology company Tessellate Bio—a firm focused on developing novel synthetic lethality approaches—has ...